Haploidentical T-Cell Depleted HSCT Represents a Safe Therapeutic Alternative to MSD Transplantation in Patients with Transfusion-dependent ß-Thalassemia Major

Authors
Publication date
1 December 2020
Publisher
Springer Nature

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Regensburg Publication Server

    redirect
    oaioai:epub.uni-regensburg.de:509...
    Last time updated on 17/12/2021